Black Rock Inc. Beyond Spring Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BYSI
# of Institutions
20Shares Held
5.28MCall Options Held
200Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.88MShares$10.4 Million1.96% of portfolio
-
Ubs Group Ag40.9KShares$87,4850.0% of portfolio
-
Tanaka Capital Management Inc New York, NY26.3KShares$56,2730.09% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$52,1470.0% of portfolio
-
Two Sigma Securities, LLC New York, NY22KShares$47,1460.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $83.3M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...